1 weight loss pill Foundayo from Eli Lilly
NBC News • • general
Key Points:
- The FDA has approved Eli Lilly's Foundayo, a new daily oral weight loss pill and the second oral GLP-1 drug on the market after Novo Nordisk's Wegovy pill.
- Foundayo comes in six doses, can be taken anytime without meal restrictions, and costs about $149 to $349 monthly out of pocket, with potential Medicare coverage starting this summer.
- Clinical trials showed Foundayo leads to an average weight loss of 12.4% at the highest dose after 72 weeks, similar to Wegovy pill but less than injectable GLP-1 options like Wegovy and Zepbound.
- Experts note that while oral pills may result in less weight loss than injections, they offer convenience and may be preferred by patients who dislike injections or want to maintain weight loss.
- Common side effects of Foundayo include gastrointestinal issues such as nausea, constipation, and diarrhea, consistent with other GLP-1 drugs.
